SGS Featured in the American Pharmaceutical Review | SGS New Zealand

November 07, 2022

American Pharmaceutical Review features our new 55,000-square-foot CDMO facility in Hudson, NH.

SGS's new facility in Hudson, NH has increased our portfolio of contract service solutions for the pharmaceutical industry. It consists of analytical and formulation labs and clinical manufacturing spaces designed to help organizations successfully bring oral and topical delivery products to market.

Read our recent article published in American Pharmaceutical Review Magazine to learn more about SGS’s CDMO solutions.

Related Links

Related Articles

SGS Laboratory in Fairfield

Business NewsMarch 01, 2024

SGS Laboratory in Fairfield, NJ, USA Achieves New ISO/IEC 17025:2017 Certification

Our laboratory in Fairfield, NJ, USA reinforces its commitment to testing excellence and ensuring the reliability and quality of drug development testing results for its global clientele.

FeaturesDecember 20, 2023

SGS Joins Forces with Agilex Biolabs

SGS has formed a strategic partnership with Agilex Biolabs, Australia’s largest and most technologically advanced regulated bioanalytical laboratory.

Patient entering Magnetic Resonance Imaging MRI scanner

FeaturesJuly 26, 2023

MDR Masters-Level Module Launched to Bolster Auditor Numbers

It is time to support the medical device sector’s demand for skilled auditors, product assessors and clinical reviewers. Find out more.

Tablets on a Black Background

Business NewsJune 26, 2023

SGS International Services Laboratory Marks Two-Year Anniversary

Two years have passed since SGS acquired International Services Laboratory in Ringaskiddy, Ireland. Here’s what we’ve achieved so far.

News & Insights

Contact Us

Send us a message

SGS New Zealand Limited

Level 1, 7 Albert Street,

Auckland Central, 1061,

Auckland, New Zealand